2017 - Fellow, National Academy of Inventors
His primary areas of study are Internal medicine, Endocrinology, Biochemistry, Cell biology and Gynecology. His work in Internal medicine addresses subjects such as Fetus, which are connected to disciplines such as Phthalate. Within one scientific family, he focuses on topics pertaining to Germ cell under Endocrinology, and may sometimes address concerns connected to Meiosis.
His research on Biochemistry often connects related topics like Molecular biology. Richard A. Anderson interconnects Pregnancy, Infertility, Fertility preservation, Fertility and Demography in the investigation of issues within Gynecology. His studies in Ovary integrate themes in fields like Andrology and Chemotherapy regimen.
His main research concerns Internal medicine, Endocrinology, Cell biology, Ovary and Biochemistry. In his study, Cancer is inextricably linked to Oncology, which falls within the broad field of Internal medicine. His Endocrinology research integrates issues from Fetus and Germ cell.
His Ovary research incorporates themes from Follicle, Andrology and Ovarian reserve. His biological study deals with issues like Gynecology, which deal with fields such as Anti-Müllerian hormone. Richard A. Anderson is involved in the study of Biochemistry that focuses on Phosphorylation in particular.
Richard A. Anderson mostly deals with Internal medicine, Percutaneous coronary intervention, Conventional PCI, Fertility preservation and Cell biology. His Internal medicine study combines topics in areas such as Endocrinology, Oncology and Cardiology. In the field of Endocrinology, his study on Luteinizing hormone and Gonadotropin secretion overlaps with subjects such as Neurokinin B.
His Percutaneous coronary intervention research is multidisciplinary, incorporating elements of Coronary artery disease, Perforation and Acute coronary syndrome. His study looks at the intersection of Fertility preservation and topics like Cancer with Pregnancy and Obstetrics. He combines subjects such as Ovary, Demography and Reproductive health with his study of Fertility.
His scientific interests lie mostly in Internal medicine, Fertility preservation, Percutaneous coronary intervention, Pregnancy and Fertility. His research integrates issues of Endocrinology, Oncology and Cardiology in his study of Internal medicine. Richard A. Anderson combines Endocrinology and Neurokinin B in his research.
His Fertility preservation study integrates concerns from other disciplines, such as Prospective cohort study, MEDLINE, Globe and Family medicine. The study incorporates disciplines such as Cancer, Endocrine system and Obstetrics in addition to Pregnancy. His Fertility research incorporates themes from Guideline, Radiation therapy and Reproductive health.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A compendium of RNA-binding motifs for decoding gene regulation
Debashish Ray;Hilal Kazan;Kate B. Cook;Matthew T. Weirauch;Matthew T. Weirauch.
Fertility preservation for young patients with cancer: who is at risk and what can be offered?
W Hamish B Wallace;Richard A Anderson;D Stewart Irvine.
Lancet Oncology (2005)
The physiology and clinical utility of anti-Müllerian hormone in women
Didier Dewailly;Claus Yding Andersen;Adam H Balen;Frank Jm Broekmans.
Human Reproduction Update (2014)
Is atrial fibrillation an inflammatory disorder
Christopher J. Boos;Richard A. Anderson;Gregory Y.H. Lip.
European Heart Journal (2006)
ESHRE Guideline: management of women with premature ovarian insufficiency
L. Webber;M. Davies;R. Anderson.
Human Reproduction (2016)
Localized biphasic changes in phosphatidylinositol-4,5-bisphosphate at sites of phagocytosis
Roberto J. Botelho;Mary Teruel;Renee Dierckman;Richard Anderson.
Journal of Cell Biology (2000)
ATP-dependent inositide phosphorylation required for Ca 2+ -activated secretion
Jesse C. Hay;Phillip L Fisette;Glenn H Jenkins;Kiyoko Fukami.
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
Pascal Vranckx;Marco Valgimigli;Peter Jüni;Christian Hamm.
The Lancet (2018)
Type Iγ phosphatidylinositol phosphate kinase targets and regulates focal adhesions
Kun Ling;Renee L. Doughman;Ari J. Firestone;Matthew W. Bunce.
Defining infertility—a systematic review of prevalence studies
S. Gurunath;Z. Pandian;Richard A. Anderson;Siladitya Bhattacharya.
Human Reproduction Update (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: